VMD
Income statement / Annual
Last year (2024), Viemed Healthcare, Inc.'s total revenue was $224.26 M,
an increase of 22.54% from the previous year.
In 2024, Viemed Healthcare, Inc.'s net income was $11.27 M.
See Viemed Healthcare, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$224.26 M |
$183.01 M |
$138.83 M |
$117.06 M |
$131.31 M |
$80.26 M |
$65.27 M |
$46.93 M |
$31.36 M |
$34.60 M |
| Cost of Revenue |
$91.05 M
|
$70.23 M
|
$54.15 M
|
$43.65 M
|
$51.20 M
|
$24.25 M
|
$16.69 M
|
$12.31 M
|
$12.50 M
|
$7.82 M
|
| Gross Profit |
$133.20 M
|
$112.78 M
|
$84.68 M
|
$73.41 M
|
$80.11 M
|
$56.01 M
|
$48.58 M
|
$34.62 M
|
$18.86 M
|
$26.78 M
|
| Gross Profit Ratio |
0.59
|
0.62
|
0.61
|
0.63
|
0.61
|
0.7
|
0.74
|
0.74
|
0.6
|
0.77
|
| Research and Development Expenses |
$3.07 M
|
$2.78 M
|
$2.70 M
|
$2.11 M
|
$1.08 M
|
$848.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$112.48 M
|
$93.73 M
|
$73.36 M
|
$60.04 M
|
$57.71 M
|
$45.27 M
|
$30.68 M
|
$20.25 M
|
$13.77 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$268.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$112.48 M
|
$93.73 M
|
$73.36 M
|
$60.04 M
|
$57.71 M
|
$45.27 M
|
$30.95 M
|
$20.25 M
|
$13.77 M
|
$16.74 M
|
| Other Expenses |
-$249.00 K
|
$1.94 M
|
$369.00 K
|
-$323.00 K
|
-$5.46 M
|
$1.03 M
|
-$71.00 K
|
$402.00 K
|
$332.00 K
|
$0.00
|
| Operating Expenses |
$115.30 M
|
$98.45 M
|
$76.43 M
|
$61.83 M
|
$53.33 M
|
$47.15 M
|
$31.54 M
|
$20.65 M
|
$14.10 M
|
$16.74 M
|
| Cost And Expenses |
$206.36 M
|
$168.68 M
|
$130.58 M
|
$105.48 M
|
$104.53 M
|
$71.40 M
|
$48.23 M
|
$32.96 M
|
$26.60 M
|
$24.56 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$87.00 K
|
| Interest Expense |
$776.00 K
|
$424.00 K
|
$197.00 K
|
$318.00 K
|
$509.00 K
|
$314.00 K
|
$181.00 K
|
$272.00 K
|
$323.00 K
|
$0.00
|
| Depreciation & Amortization |
$25.37 M
|
$21.86 M
|
$15.63 M
|
$11.31 M
|
$9.58 M
|
$6.40 M
|
$3.78 M
|
$2.54 M
|
$1.42 M
|
$955.09 K
|
| EBITDA |
$42.31 M |
$36.68 M |
$24.82 M |
$24.13 M |
$36.45 M |
$15.51 M |
$13.89 M |
$11.37 M |
$1.81 M |
$11.94 M |
| EBITDA Ratio |
0.19
|
0.2
|
0.18
|
0.21
|
0.28
|
0.19
|
0.21
|
0.24
|
0.06
|
0.34
|
| Operating Income Ratio |
0.08
|
0.08
|
0.06
|
0.1
|
0.2
|
0.11
|
0.26
|
0.19
|
0.01
|
0.29
|
| Total Other Income/Expenses Net |
-$1.73 M
|
$61.00 K
|
$738.00 K
|
$923.00 K
|
-$418.00 K
|
-$61.00 K
|
-$386.00 K
|
-$633.00 K
|
-$274.00 K
|
-$87.00 K
|
| Income Before Tax |
$16.17 M
|
$14.39 M
|
$8.99 M
|
$12.50 M
|
$26.36 M
|
$8.80 M
|
$10.34 M
|
$8.19 M
|
$109.00 K
|
$9.96 M
|
| Income Before Tax Ratio |
0.07
|
0.08
|
0.06
|
0.11
|
0.2
|
0.11
|
0.16
|
0.17
|
0
|
0.29
|
| Income Tax Expense |
$4.76 M
|
$4.15 M
|
$2.77 M
|
$3.38 M
|
-$5.17 M
|
$271.00 K
|
$162.00 K
|
$15.00 K
|
-$1.12 M
|
$1.03 M
|
| Net Income |
$11.27 M
|
$10.24 M
|
$6.22 M
|
$9.13 M
|
$31.53 M
|
$8.53 M
|
$10.18 M
|
$8.18 M
|
$1.23 M
|
$8.93 M
|
| Net Income Ratio |
0.05
|
0.06
|
0.04
|
0.08
|
0.24
|
0.11
|
0.16
|
0.17
|
0.04
|
0.26
|
| EPS |
0.29 |
0.27 |
0.15 |
0.23 |
0.86 |
0.23 |
0.27 |
0.22 |
0.0324 |
1.49 |
| EPS Diluted |
0.28 |
0.25 |
0.15 |
0.22 |
0.82 |
0.22 |
0.26 |
0.22 |
0.0324 |
1.49 |
| Weighted Average Shares Out |
$38.76 M
|
$38.35 M
|
$38.66 M
|
$39.49 M
|
$38.74 M
|
$37.72 M
|
$37.89 M
|
$37.91 M
|
$37.91 M
|
$6.00 M
|
| Weighted Average Shares Out Diluted |
$40.81 M
|
$40.38 M
|
$39.81 M
|
$40.68 M
|
$40.53 M
|
$39.75 M
|
$39.68 M
|
$37.97 M
|
$37.91 M
|
$6.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
